Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W7GQ
|
||||
Former ID |
DIB019805
|
||||
Drug Name |
EGIS-7625
|
||||
Synonyms |
EGIS-7625
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539109] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H22N4O2
|
||||
InChI |
InChI=1S/C18H22N4O2/c1-14-11-18(22(23)24)17(12-16(14)19)21-9-7-20(8-10-21)13-15-5-3-2-4-6-15/h2-6,11-12H,7-10,13,19H2,1H3
|
||||
InChIKey |
ZEFXWOMFCPRXJW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Antagonist | [527053] | |
5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [527053] | ||
5-hydroxytryptamine 2A receptor | Target Info | Antagonist | [527053] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.